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Differentiationoding RNAs that regulate protein expression by binding 3′UTRs of target mRNAs,
thereby inhibiting translation. Similar to siRNAs, miRNAs are cleaved by Dicer. Mouse and ES cell Dicer
mutants demonstrate that microRNAs are necessary for embryonic development and cellular differentiation.
However, technical obstacles and the relative infancy of this ﬁeld have resulted in few data on the functional
signiﬁcance of individual microRNAs. We present evidence that miR-17 family members, miR-17-5p, miR-
20a, miR-93, and miR-106a, are differentially expressed in developing mouse embryos and function to
control differentiation of stem cells. Speciﬁcally, miR-93 localizes to differentiating primitive endoderm and
trophectoderm of the blastocyst. We also observe high miR-93 and miR-17-5p expression within the
mesoderm of gastrulating embryos. Using an ES cell model system, we demonstrate that modulation of these
miRNAs delays or enhances differentiation into the germ layers. Additionally, we demonstrate that these
miRNAs regulate STAT3 mRNA in vitro. We suggest that STAT3, a known ES cell regulator, is one target mRNA
responsible for the effects of these miRNAs on cellular differentiation.
© 2008 Elsevier Inc. All rights reserved.IntroductionMicroRNAs (miRNAs) are short, non-coding RNAs that negatively
regulate target mRNAs via binding to their 3′ untranslated regions
(UTRs). Although miRNA silencing is mediated through the RNA-
induced silencing complex (RISC), its binding does not generally result
in mRNA cleavage, as is the case with siRNA. The miRNA-RISC
association results in the formation of a bulge within the miRNA,
preventing cleavage and explaining the relatively low level of target
complimentarity necessary for silencing (Chu and Rana, 2006).
Speciﬁcally, Watson–Crick base pairing between the target mRNA
and nucleotides 2–8 at the 5′ end of the miRNA, frequently referred to
as the “seed region,” is generally believed to determinemiRNA binding
potential (Lewis et al., 2003). Following miRNA binding, mRNAs are
silenced either by storage in P-bodies or degradation via mRNA decay
pathways (Gregory et al., 2005; Rana, 2007; Zeng et al., 2003).
Newly published literature has implicated miRNA-mediated silen-
cing as having important regulatory functions during embryonic
development and embryonic stem (ES) cell proliferation and differentia-
tion (Boyer et al., 2005; Hatﬁeld et al., 2005; Houbaviy et al., 2003;
Kanellopoulou et al., 2005; Krichevsky et al., 2006; Murchison et al.,
2005; Shcherbata et al., 2006; Wang et al., 2007; Zhao et al., 2005). Theic stem (cell); ICM, Inner cell
ing complex; STAT3, Signal
slated region.
.
l rights reserved.miR-17 family of miRNAs, which is expressed as three polycistronic
clusters, is highly conserved throughout species and is thought to have
evolved along with vertebrates (Tanzer and Stadler, 2004). Through
evolution, a series of duplications, deletions and mutations have given
rise to the modern miR-17 family, which consists of 14 mature miRNAs
located on chromosomes 13, X and 7 in humans. Hinting at the
importance of thesemiRNAs, these 14 genes also exist in the same order
andas three clusters inmouse, rat, and chimp (Tanzer and Stadler, 2004).
To date few miRNAs have been speciﬁcally investigated during
embryonic development (Ventura et al., 2008; Zhao et al., 2007).
When deleted via gene targeting, miR-1-2 null mice showed
developmental defects including disrupted cardiac morphogenesis
and failed electrical conduction in cardiomyocytes. Most recently,
deletion of miR-17 family members miR-92, 106a, and 106b also
revealed developmental defects (Ventura et al., 2008). In addition,
new reports have shown these miRNAs to be involved in zebraﬁsh
development (Giraldez et al., 2005), cancer progression (Dews et al.,
2006; He et al., 2005), and hematopoietic cell differentiation (Garzon
et al., 2006). Within zebraﬁsh, miR-430, a member of the miR-17
family, was shown to be important for development of both the heart
and hindbrain (Giraldez et al., 2005). A second study examined the
role of c-myc in the regulation of expression of the miR-17 cluster
(O'Donnell et al., 2005). They demonstrated that c-myc directly
activated transcription of miR-17 family microRNAs, which then
bound to upstream regulators and downstream targets of myc.
Additionally, several members of the miR-17 family, including miR-
17-5p, miR-20a, miR-93, and miR-106a have been identiﬁed as
microRNAs that are speciﬁcally expressed in undifferentiated or
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2004; Tang et al., 2006). Interestingly, these same 4 microRNAs, which
exhibit high sequencesimilarity (Fig.1A),were among those identiﬁedby
at least 3 different algorithms as possible binding partners to the 3′-UTR
of theSignal Transducer andActivator of Transcription3 (STAT3) (Fig.1B).
Based on the current miRNA literature and the knowledge that STAT3
interacts with myc in ES cells (Cartwright et al., 2005), hematopoiesis
(Hirano et al., 2000), and cancer (Barre et al., 2005), we hypothesize that
miR-17 family members are expressed during embryonic development
andregulate cellulardifferentiationby targetingofmRNAs suchas STAT3.
STAT3, a downstream transcription factor in the JAK-STAT signal
cascade, is an important player in both developmental and stem cell
biology. Surprisingly, few investigations exist describing STAT3 prior
to implantation (Antczak and Van Blerkom,1997; Duncan et al., 1997);
however, STAT3 knockout mice are embryonic lethal just prior to
gastrulation at E6.0–6.5, and exhibit functional failure of the visceral
endoderm and a lack of mesoderm formation (Takeda et al., 1997).
While this developmental lesson alludes to the important role STAT3
plays in many tissue types, the constitutive activation of STAT3 in
several cancers demonstrates that this protein must also be tightly
regulated (Catlett-Falcone et al., 1999; Corvinus et al., 2005; Nefedova
et al., 2004). STAT3 is negatively regulated by at least 4 known
mechanisms, including various phosphatases, expression of its
endogenous dominant negative isoform, STAT3β, and negative feed-
back loops created by expression of Suppressors of Cytokine Signaling
(SOCS) and Protein Inhibitors of Activated STATs (PIAS) proteins
(Horvath, 2000; Inagaki-Ohara et al., 2003). Previous work from our
laboratory and others has demonstrated that several of these
mechanisms operate simultaneously at the onset of ES cell differ-
entiation to induce a rapid and drastic decrease in STAT3 activity
(Chan et al., 2003; Feng, 2007; Foshay and Gallicano, 2008; Foshay et
al., 2005; Li et al., 2005). Our previous data suggest that the degree and
duration of this period of STAT3 inactivity may affect cell fate choices
over the course of differentiation. Thus, as STAT3 regulation by several
different methods appears to be critical for proper ES cell differentia-
tion, we hypothesize that miRNAs may exert their effects on
differentiation through this key developmental regulator.
Although asmany as 50miRNAs are predicted to bind the 3′-UTR of
STAT3, there are only two reports of miRNA-mediated regulation of
STAT3 in the current literature. In both cases, the investigators
demonstrate that levels of STAT3 phosphorylation can be indirectly
affected by miRNAs in neural cell differentiation and in cancer
(Krichevsky et al., 2006; Meng et al., 2007). However, our data is the
ﬁrst to elucidate a STAT3/miR-17 family member(s) interaction, which
results in a functional regulation of ES cell differentiation.
Materials and methods
ES cell culture and differentiation
CCE ES cells (Keller et al., 1993; Robertson et al., 1986), obtained
from Stem Cell Technologies, Inc., were grown in feeder freeFig. 1. (A) The mature miRNA sequences for miR-17-5p, miR-20a, miR-93, and miR-106a.
These 4 miRNAs are predicted to bind STAT3. (B) The 2 predicted miR-17 family binding
sites on the STAT3 3′UTR. Binding sites and miRNA nucleotides are aligned to shown
conservation (black— both binding sites; blue— site 1; green— site 2). All 4 miRNAs share
the same seed region, which is perfectly complementary to both STAT3 binding sites.conditions with media containing 15% ES cell qualiﬁed FBS (Invitro-
gen, Carlsbad, CA). Differentiation of ES cells was induced by removal
of LIF and transfer to suspension culture.
Embryo procurement
Blastocysts and implanted embryos were obtained as described in
Gallicano and Capco (1995) and Gallicano et al. (1998). Brieﬂy, one
female is placed into a cage with one male to allow copulation.
Females are checked the next day for vaginal plugs, which represents
0.5 days post coitum. Eighty four hours later, themouse is sacriﬁced by
CO2 asphyxiation, the female reproductive tract is removed, and
blastocysts are ﬂushed from the uterus using a 26 3/4 gauge needle
attached to a 10 cm3 syringe ﬁlled with medium. For in situ
hybridization and confocal microscopy, blastocysts were transferred
to 4.0% paraformaldehyde ﬁxative for 1 h.
Implanted embryos were obtained from fertilized dames post-
humously 5.5 days, 6.0 days, and 6.5 days post coitum by dissection
from decidua and using Dumont #5 forceps. Isolated embryos were
then placed in 4.0% para-formaldehyde and processed for either in situ
hybridization or immunohistochemistry.
Removal of cells from blastocysts
Blastocysts were used to extract and isolate cells from three areas,
trophectoderm, ICM, and presumptive primitive endoderm. To do so,
blastocysts were placed in a watch glass containing 0.25% trypsin for 5–
10 min until the cells comprising the blastocyst began dissociating. A
pulled glass needle similar to those used for ES cell injection into
blastocysts was used to extract three cells from each region of the
blastocyst using an Eppendorf TransferManNK2micromanipulator set on
negative pressure. This technique is simply the opposite of the technique
used to inject blastocysts with ES cells. Once three cells were removed
theywere thenplaced into amicrocentrifuge tube containing theqRT-PCR
buffer supplied by themirVanamiRNA Isolation Kit (Ambion, Austin, TX).
Immunoﬂuorescence and confocal microscopy
Embryos were ﬁxed in 4% fresh paraformaldehyde for 30 min
followed by permeabilization overnight at 4 °C. Following blocking for
1 h, embryos were incubated in primary antibody at a 1:50 dilution
overnight at 4 °C. Incubation with secondary antibodies was
conducted for 3 h at room temperature. Antibodies: STAT3 #9132
from Cell Signaling (Danvers, MA); CK8/18 #03-GP11 from ARP
(Belmont, MA). Slides were viewed using an Olympus Fluoview 500
Laser Scanning Microscope (Olympus America Inc, Melville, NY) using
1.4 numerical aperture. Images were acquired and analyzed using the
accompanying Fluoview software (version 4.3).
In situ hybridization
In situ hybridization probes were obtained from Exiqon (Woburn,
MA) and experiments were performed according to the GEISHA
protocol (from the University of Arizona) available on the Exiqon
website. All reagents and apparatus used were DEPC treated.
Hybridizations were conducted overnight at 58 °C.
miRNA binding predictions
Bindingpredictionsweremadebycomparing resultsof threedifferent
miRNA prediction programs, each of which utilizes a different prediction
algorithm. The miRBase website (http://microrna.sanger.ac.uk/targets/
v4/), run by the Sanger Institute, employs the miRanda algorithm to
predict miRNA:mRNA pairs. MicroInspector, another web-based miRNA
search program (http://mirna.imbb.forth.gr/microinspector/), run by the
Institute forMolecular BiologyandBiotechnology,Heraklion,Greece, uses
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we used a custom made miRNA prediction program, written by Bill
Foshay, which utilizes a variation of the TargetScanS algorithm (Lewis et
al., 2005) and components of the Vienna RNA secondary structure
programming library (RNAlib) (http://www.tbi.univie.ac.at/~ivo/RNA/
RNAlib.html), which obtains RNA energy parameters from the Turner
laboratory (http://rna.chem.rochester.edu/). The PicTar miRNA website
(http://pictar.bio.nyu.edu/) was also used for generating Table 2.
qRT-PCR
All RNA samples were prepared by extraction with the mirVana
miRNA Isolation Kit (Ambion, Austin, TX). Samples were treated with
DNaseI to digest any contaminating genomic DNA and diluted to
10 ng/μL. All primers were designed by and purchased from Applied
Biosystems (Foster City, CA). All RT and qPCR reagents were also
purchased from Applied Biosystems. No-RT controls were performed
for both miRNA and mRNA qRT-PCRs. Individual samples were run in
triplicate, and each experiment was repeated at least 3 times. All
samples were run on the Applied Biosystems ABI Prism 7700 system
using SDS 2.1 software. Relative gene expression was calculated using
the 2−ΔΔCT method (Livak and Schmittgen, 2001).
Western blots
Western blots were performed using precast 7.5% Tris–HCL
polyacrylimide gels and run on the BioRad mini gel system (Hercules,
CA). Proteins were transferred to PVDF membranes and blocked in a
solution of 2% BSA and 5%milk in PBS-T. The STAT3 antibody, available
from Cell Signaling (Danvers, MA), was used at a 1:1000 dilution.
Bands were visualized using colorimetric detection and exposure to
autoradiography ﬁlm. Similar exposure timeswere used for STAT3 and
tubulin blots to ensure appropriate normalization. Quantiﬁcation of
bands was performed using Adobe Photoshop CS to calculate the pixel
intensity of each band. Pixel intensities for STAT3 and tubulin were
expressed as a ratio to generate a normalized value for STAT3
expression.
DNA constructs and transient transfections
All transient transfections were performed using the TransIT-LT1
or TransIT-TKO reagents from Mirus Bio Corporation (Madison, WI).
Transfection reactions were prepared according to protocols provided
with the reagent. For differentiation experiments, undifferentiated ES
cells were transfected and 24 h post-transfection (d0) cells were
harvested or placed into suspension culture for differentiation. The
pMIR-REPORT and pRL-CMV constructs are commercially available
from Ambion (Austin,TX) and Promega (Madison, WI), respectively.
pMIR-REPORT 3′UTR inserts are as follows: pMIR-miR20 contains two
synthesized binding sites that are complimentary to miR-20, pMIR-
Hoxa11 contains the Hoxa11 3′UTR, pMIR-S3 contains part of the
STAT3 3′UTR including the two putative miRNA binding sites, pMIR-
S3st1mt contains the STAT3 3′UTR with 4 point mutations in the ﬁrst
miRNA binding site, pMIR-S3st2mt contains 4 point mutations in the
second miRNA binding site, pMIR-S32xmt contains 4 point mutations
in each of the two miRNA binding sites. All miRNA mimics and
inhibitors were designed by and purchased from Dharmacon (Lafay-
ette, CO). The mimics are duplexes and therefore the concentration of
active miRNA mimic (strand loaded into RISC) within the cell is about
50 nM or half of the total transfected concentration (100 nM).
Inhibitors are single stranded.
Luciferase assays
Luciferase assays were conducted following transient transfections
of pMIR and pRL-CMV constructs at a 15:1 ratio. Cells were harvestedaccording to speciﬁcations of the Dual Luciferase Reporter Assay Kit
(Promega) and 20 μL of the lysate was transferred to each well of a 96
well plate for analysis. For experiments in undifferentiated ES cells,
lysates were prepared 48 h post-transfection. For differentiation
experiments, undifferentiated cells were transfected and placed into
suspension culture without LIF 24 h post-transfection (d0). The
luciferase reactions were conducted using theWallac VICTOR2 96-well
plate reader at the Lombardi Cancer Center Shared Resource. All
luciferase data are presented as a normalized ratio of luciferase/
Renilla.
Results
miR-17 family miRNAs are differentially expressed in developing
mouse embryos
Based on our hypothesis that miR-17 family miRNAs are important
for embryonic development we sought to determine their expression
patterns in early mouse embryos. Because this family of miRNAs is
transcribed from the genome as three polycistronic clusters, which are
regulated by c-myc, we expected to ﬁnd the mature miR-17 family
miRNAs expressed at similar levels and within the same regions of the
embryos.
In our ﬁrst set of experiments, we identiﬁed the expression
patterns of miR-17-5p, miR-20a, miR-93 and miR-106 in E4.0
blastocysts by in situ hybridization (ISH) using locked nucleic acid
(LNA) miRNA speciﬁc probes. Despite their small size and sequence
similarity, the highly stable LNA probes allowed us to use increased
hybridization temperatures relative to conventional in situ protocols
(Kloosterman et al., 2006; Nelson et al., 2006). As a result, we
determined distinct embryonic localization patterns for each miRNA.
Speciﬁcally, miR-17-5p and miR-20 were seen throughout the
blastocyst, with a slight increase in hybridization seen within cells
of the trophectoderm (Fig. 2A). Low levels of miR-106a signal were
also observed throughout blastocysts; however, elevated levels of
miR-106a hybridization were clearly evident in the inner cell mass
(ICM) (Fig. 2A). The most striking expression pattern was that of miR-
93. This miRNA was restricted to the trophectoderm and the future
primitive endoderm. Additionally, miR-93 expression was barely
detectable within the ICM (Fig. 2A). We also noticed that the signals
for miR17-5 and miR-20 were scattered throughout the cytoplasm.
However the signal for miR-93 was enriched to one side of the
cytoplasm in select cells. Although we were surprised to see both
subtle as well as distinctly different miRNA expression patterns
between family members, our observations ﬁt well with our original
hypothesis; that the highest miRNA expression would be found in
differentiating tissues. These data suggest that miR-17 family miRNAs
may play a role in embryonic development and differentiation.
Because we hypothesized that these miRNAs may exert their
effects via STAT3, we next looked at STAT3 expression in the
blastocysts. As expected, STAT3 expression was speciﬁc to the ICM
with little or no staining seen in the trophectoderm and the
presumptive primitive endodermal ICM cells that line the blastocoelic
cavity (Fig. 2B). This expression patternwas opposite to that ofmiR-93,
suggesting that endogenous miR-93 may downregulate STAT3 in
speciﬁc cells of the blastocysts.
We continued our investigation of miR-17 family expression
patterns, conducting in situ hybridization in E5.5 and E6.5 embryos
(Figs. 3 and 4). At E5.5 we saw strong hybridization of all probes in the
extraembryonic cells (Figs. 3A–D). These cell types include the
extraembryonic ectoderm and the visceral endoderm, which, at
E5.5, are differentiating into specialized tissues that will form the
yolk sac and placenta, and facilitate nutrient and gas exchange for the
embryo. In contrast, the primitive embryonic ectoderm, or epiblast, is
still undifferentiated at this stage. These cells, which are rapidly
proliferating in preparation for gastrulation, showed little or no
Fig. 2. (A) In situ hybridization of mature miRNAs in blastocysts stage embryos. miR-17-5p and miR-20a showed generally even expression through the cells of the blastocyst. A mild
increase in hybridization of bothmiRNAswas detected in the trophectoderm (yellow arrow). miR-93 showed themost distinctive expression patternwith very little signal in the cells
of the ICM and a drastic upregulation in both the putative primitive endoderm (white arrowhead) and trophectoderm (yellow arrow). miR-106a showed very speciﬁc staining in the
ICM (blue arrowhead), although levels appeared relatively equal in all cell types. Cells with the highest miRNA expression were those undergoing differentiation (i.e. putative
primitive endoderm and trophectoderm). A probe to cel-miR-159 (a C. elegansmiRNA not found in mouse) is used as a negative control. The embryos shown are representative of 6–
10 embryos for each miRNA tested. (B) Immunoﬂuorescence of blastocyst stage embryos showed that STAT3 is localized to the ICM, an expression pattern opposite of miR-93.
Arrowheads point to putative primitive endoderm that has little or no STAT3 staining. Anti CK8/18 staining clearly labeled the trophectoderm, which shows low levels of STAT3
staining. The embryo shown is a representative of 10 embryos from three experiments. (C) A schematic drawing of a blastocyst stage embryo to demonstrate the orientation of the
blastocysts shown in panels A and B.
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correlate with the blastocyst ISH data (Fig. 2) and demonstrate the
idea that miR-17 family miRNAs are upregulated in differentiating cell
types of the developing embryo.
In addition to the in situ studies, we performed immunohis-
tochemistry for STAT3 expression on parafﬁn embedded sections of
E5.5 embryos (Fig. 3E). These sections showed high levels of
speciﬁc nuclear STAT3 staining throughout the epiblast, suggesting
that STAT3 is active in this area. We detected little or no STAT3 inthe visceral endoderm and low levels in the extraembryonic
ectoderm. Taken together, these data present an expression pattern
for STAT3 that is opposite of miR-17 family expression in E5.5
embryos (Figs. 3A–E).
At E6.5, embryos showed highly speciﬁc miRNA expression
patterns. All four of the miRNA investigated were localized to the
posterior end of the primitive streak (Figs. 4A–D). Interestingly, the
hybridization was restricted to ectoderm cells at least one cell layer
removed from the primitive streak. Thus, the posterior primitive
Fig. 3. (A–D) Whole mount in situ hybridization of E5.5 mouse embryos. At this stage in development, expression of the miR-17-5p, miR-20a, miR-93 and miR-106a is high in the
differentiating extraembryonic cells that will form the tissues that support growth of the epiblast. The embryonic ectoderm, or epiblast, is relatively undifferentiated at this stage of
development. These cells exhibit little or no miR-17 family miRNA expression. (E) Immunohistochemistry for STAT3 expression in an E5.5 embryo section. STAT3 (brown) is localized
to the nuclei within the epiblast or primitive ectoderm. Little if any staining is observed in the visceral endoderm or extraembryonic ectoderm. (A–E) cone — ectoplacental cone;
eve — extraembryonic visceral endoderm; ve — visceral endoderm; p-ect — primitive ectoderm; p-exe — primitive extraembryonic ectoderm; pa — proamniotic cavity.
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of the miRNAs. However, gastrulating cells, which were in the process
of differentiating into mesoderm or mesendoderm expressed high
levels of miR-93 and miR-17-5p (Figs. 4A, B). Although, in some cases
brightly positive cells were observed within the endoderm, generally
the visceral endoderm had low miRNA expression. These cells may be
intercalating mesendoderm cells that will form the deﬁnitive
endoderm. From these data we suggest that miR-17 family miRNAs
are expressed in cells that are approaching the primitive streak,
followed by virtually complete downregulation as they prepare to
pass through the primitive streak. As these cells engress and
differentiate, miR-17-5p and miR-93 are upregulated, most likely
downregulating translation of mRNAs that are speciﬁc to theectoderm or are involved in proliferation. The patterns of ISH and
STAT3 expression from blastocysts, E5.5 and E6.5 embryos are
summarized in Table 1.
Of note is the drastic difference in miRNA expression within
extraembryonic and embryonic visceral endoderm of E6.5 embryos.
While the embryonic visceral endoderm has low expression of all
testedmiRNAs, miR-20a andmiR-106a are expressed at relatively high
levels in the extraembryonic visceral endoderm (Figs. 4C, D, eve). The
hybridization patterns are extremely speciﬁc with miRNAs being
detected speciﬁcally in the cytoplasm and at the periphery of cells. In
fact, the lack of signal in the nucleus for any of the miRNA probes
would suggest that they are relatively speciﬁc for the processed,
mature miRNA and not the unprocessed Pri-mRNA.
Fig. 4. (A–E) In gastrulation stage embryos (E6.5–E6.75) miR-17-5p (A), miR-20a (C), miR-93 (B) andmiR-106a (D) are all localized to ectoderm cells one cell layer away from primitive
streak ectoderm (white arrows). In addition, miR-17-5p and miR-93 showed speciﬁc upregulation in differentiating mesoderm cells (A, small arrowheads). In most cases miRNA
expressionwas low in the visceral endoderm (A–D, large arrowheads). A few bright cells within the visceral endoderm are thought to be intercalating mesendoderm cells. Note: miR-
93 is speciﬁcally found in differentiating cells of both blastocyst and gastrulation stage embryos (B and Fig. 2). (F) Immunohistochemistry of an E6.75, gastrulating embryo
demonstrated elevated levels of STAT3 protein in ect (black arrowheads) not associated with the primitive streak. eve— extraembryonic visceral endoderm; ve— visceral endoderm;
me — mesoderm; ect — ectoderm; amn — amniotic cavity; dec — deciduas; cone — ectoplacental cone.
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chemistry for STAT3 expression on parafﬁn embedded sections of E6.5
embryos (Fig. 4F). While these sections showed high levels of speciﬁc
nuclear STAT3 staining in the ectoderm (ect), cells near the posterior
primitive streak appear devoid of STAT3, suggesting that STAT3 is
inactive in this area.We detected little or no STAT3 in nuclei of visceral
endoderm and low levels in the extraembryonic ectoderm.miRNAs -17, 20a, -93 and 106a are expressed in blastomere and ES cells
To test our hypothesis that miR-17-5p, miR-20a, miR-93 and miR-
106a are involved in regulation of differentiation during embryonic
development we used two model systems; isolated cell-types from
blastocysts and ES cells. By conducting our studies in vitro we could
easily manipulate individual miRNAs and assess their effects on cell
Table 1
Expression of miRNAs and STAT3 in developing embryos
Blastocyst (E4.0) E5.5 E6.5
ICM PE TE PEct Exe VE PS Ect Mes VE
miR-17-5p + + ++ + ++++ ++++ − +++ +++ +++
miR-20a + + ++ − + − − ++ + +
miR-93 ++ ++++ ++++ − +++ ++ − +++ +++ +++
miR-106a ++ ++ ++ − ++++ ++++ − +++ + +
Differentiating
cell type
N Y Y N Y Y N Y Y Y
STAT3 ++++ − + ++++ ++ − ++++ +++ − +
This table summarizes the expression levels of miR-17-5p, miR-20a, miR-93, miR-106a,
and STAT3 during early embryonic development as determined by in situ hybridization
and immunostaining (Figs. 2, 3, and S1).
(–) below level of detection; (+) low level of expression; (++) level of expression slightly
higher than (+); (+++) strong expression; (++++) highest expression; N, No; Y, Yes.
Fig. 5. Change in miRNA expression after differentiation. (A) Mature miRNA expression
in E4.0 blastocyst cell types was examined by qPCR. miR-93 expression was highest
throughout the blastocyst, but showed a 10-fold increasewhen cells differentiated from
the ICM to the primitive endoderm or trophectoderm. In general these data correlate to
expression proﬁles determined by in situ hybridization. (B) miRNA expression
differences between ES cells and ICM. In ES cells miR-20 was expressed at higher
levels than the other miR-17 family miRNAs. (C) Expression analysis of the miR-17
family members over the course of ES cell differentiation revealed distinct patterns
directly related to differentiation. In most cases, (e.g., miR-93, miR-106a) expression
virtually doubled within the ﬁrst 3 days of ES cell differentiation. (A–C) Each RT reaction
was performed three times, and each qPCR sample was run in triplicate. Relative gene
expression was calculated using the 2−ΔΔCT method using U6 snRNA for normalization
(Livak and Schmittgen, 2001). Data are presented as the mean±the SEM.
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in blastocysts from isolated trophoblast cells, pluripotent ICM, and
ICM destined to become primitive endoderm. We also used qRT-PCR
to analyze miRNA expression in ES cells (Fig. 5). Using this approach,
we were able to quantitatively compare changes in miRNA expression
as cells of the blastocyst differentiated into primitive endoderm and
trophectoderm.
It is important to note how these data were controlled for this set
of experiments. All qRT-PCR samples were normalized to qRT-PCR of
U6 snRNA using the delta-delta Ct method. Then, to make the data
easier to interpret, one sample (generally the one with the lowest
overall value) was picked and set to 1 serving as the baseline. The
other samples were then compared to the baseline sample for each
graph in Fig. 5. In Fig. 5A, miR-20 was set as the baseline and
expression of the other miRNAs is compared to miR-20. In Fig. 5B,
miRNA-106a was set as the baseline and expression of the other
miRNAs is compared to miRNA-106a. The baselines were set
differently because miRNA expression was different when comparing
ES cells to blastocysts (see below).
Within the blastocyst, miR-93 was expressed at levels higher than
any other tested miRNA (Fig. 5A). Interestingly upon extraction and
analyzing three cells per experiment from the three areas within the
blastocyst, miR-93 was the only miRNA that was signiﬁcantly
upregulated in the putative primitive endoderm and trophectoderm.
Thus, these qRT-PCR data supported the results previously found
using in situ hybridization (Fig. 2). To this end, miR-17 and miR-20
expression levels were relatively consistent across cell types, while
miR-106a was highest in the ICM. Since these data matched our in situ
hybridization data (Fig. 2), we determined that qRT-PCR would be the
best method for measuring miRNA expression in ES cells.
Surprisingly the miRNA expression proﬁle of ES cells was different
than that of blastocyst ICM cells. In cultured ES cells, miR-20
expression was higher than any other tested miRNA, miR-17-5p and
miR-93 displayed equal expression levels, and miR-106a was the
lowest (Fig. 5B). Despite the differences between baseline miRNA
expression in ES cells and ICM cells, the upregulation of these miRNAs
during differentiation was consistent (Fig. 5C). Speciﬁcally, when
compared to miR-93 expression in undifferentiated ES cells, miR-93
expression nearly doubled during the ﬁrst three days of ES cell
differentiation. While miR-106a expression also increased, this
occurred approximately 2 days later than the miR-93 increase,
suggesting miR-106 may play a different role in differentiation. Both
miR-20 and miR-17 exhibited slight increases over the course of
differentiation, thus supporting the blastocyst qRT-PCR and in situ
data.
Differentiation of individual blastomeres within blastocysts occurs
more synchronously than differentiation of individual cells within an
EB. Therefore, we surmise that the lower fold increase in miRNA
expression in ES cells when compared to blastomeres is due to
decreased temporal regulation of differentiation. Based on thiscomparison of ES and blastocyst differentiation, we have demon-
strated that differences between the in vivo niche and cell culture
conditions may alter basal miRNA expression levels. This could be due
to the mix of growth factors present in the fetal bovine serum used to
culture ES cells. It is also possible that in ES cell culture Drosha
functions differently than in embryos, and thus changes in miRNA
expression may be due to differential post-transcriptional processing
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expression could be attributed to the fact that ES cells in culture do not
interact with a supportive trophectodermal niche.
Although we found differences between miRNA expression in vivo
and in vitro, we demonstrated a consistent upregulation of miR-93
upon initiation of differentiation in both cultured ES cells and in
developing blastocysts. These data suggest that miR-93 is an
important miR-17 family member for regulating cellular
differentiation.
Changes in miRNA expression can alter cell fate during ES
cell differentiation
To test the hypothesis that miR-17 family miRNAs affect cell fate
during differentiation, we transfected mimics or inhibitors of miR-93
and miR-20 into undifferentiated ES cells (a non-speciﬁc inhibitor/
mimic was used as a negative control). This transient transfectionwas
followed by a second transfection once differentiation had begun (day
2; 72 h after ﬁrst transfection). The cells were allowed to differentiate
as EBs in suspension culture for up to 7 days (day 7). RNA was
harvested at days 0, 3 and 7 and was then used for qRT-PCR analysis of
germ layer speciﬁc differentiation markers (Fig. 6). Levels of mature
miRNA within the cell were also measured by qRT-PCR in an effort to
demonstrate the effectiveness of the transfection (Fig. S1). Because of
the large scale of this experiment, we chose only to use inhibitors to
miR-20 and miR-93. Our rationale stemmed from the strong in vivo
data suggesting thatmiR-93was themost likely candidate regulator of
stem cell differentiation. As expression of the other miRNAs seemed
less speciﬁc to differentiating cells, we chose to examine only miR-20,
which we felt was representative of the other 3 miRNAs.
Upon transfection of inhibitors we saw a statistically signiﬁcant
decrease in Fgf-5 expression when compared to controls only at d0.
These data suggest that ectodermal differentiationwas not affected by
the miRNA inhibitors (Fig. 6A). However, miR-93 inhibitors disrupted
endodermal differentiation. In these cells Hnf4a levels were signiﬁ-
cantly lower at the onset of differentiation (24 h post transfection) and
remained low even after several days of culture in differentiating
conditions (Fig. 6B). Interestingly, the inhibitors also delayed the
expression of the mesodermal differentiation marker, Brachyury, (Fig.
6C, d3). Based on these data we suggest that miRNAs exhibit different
effects on different germ layers. As evidenced from our in vivo ISH
data, these miRNAs are quite low in the ectoderm or epiblast (Fig. 3)
and therefore their inhibition may not drastically effect differentia-
tion. Additionally, our in vitro data support our in vivo data and
suggest that miR-93 is, in fact, a more potent inducer of differentiation
than miR-20 or other miR-17 family members.
When the opposite experiment was conducted, and miR-93
mimics were transfected, we saw a signiﬁcant increase in Brachyury
expression (Fig. 6F). However, this increase was not observed upon
transfection of miR-20 mimics. Again, these data support a functional
role for miR-93 in regulation of ES cell differentiation. Additionally,
these data suggest that upregulation of miR-93 may promote
mesodermal differentiation. This idea is supported by the strong
mesodermal expression of miR-93 in gastrulating embryos (Fig. 4B).
Taken together, our data demonstrate the ﬁrst functionally signiﬁcant
role for miRNAs in regulation of ES cell differentiation in vitro.
In addition to qRT-PCR analysis, we observed the effects of miR-93
mimics and inhibitors on EBs using H&E staining (Figs. 6G–I).
Following the same procedure outlined above, transfected cells wereFig. 6. (A–F) Transfection of miR-20 or miR-93 inhibitors or mimics affects fate commitment i
suspension culture without LIF 24 h post-transfection (d0). RNA was collected for qRT-PC
differentiation, as evidenced by signiﬁcantly lower levels of Fgf-5 expression. The miR-93 inh
both at the onset of differentiation and after 7 days under differentiating conditions. Neith
mimic tomiR-93 did cause a signiﬁcant upregulation in brachyury, a mesodermmarker. (G–I)
embedded in parafﬁn for H&E staining. In controls or EBs transfected with miR-93 mimics (
apparent. In EBs transfected with miR-93 inhibitors, these cells are absent.allowed to differentiate for up to 10 days in culture. EBs were
harvested, ﬁxed, and sectioned for staining. EBs transfected with miR-
93 inhibitors were comprised of homogeneous cells, as compared to
controls or miR-93 mimic transfected cells. In addition, EBs trans-
fected with miR-93 inhibitors lacked the outer layer of visceral
endoderm that is commonly found in differentiating EBs (Fig. 6, black
arrows). These histological data agree with our qRT-PCR data and
support the conclusion that inhibition of miR-93 prevents differentia-
tion of ES cells.
miR-20 and miR-93 can bind the STAT3 3′UTR and decrease
STAT3 expression
Data from our previous studies demonstrated that STAT3 is
important not only for pluripotency, but also for differentiation of
mesodermally and ectodermally derived cells (Foshay and Gallicano,
2008; Foshay et al., 2005). Additionally, miR-93 and other miR-17
family members are predicted to target the 3′UTR of STAT3 (Fig. 1B).
The results of the mimic and inhibitor transfection experiments could
be explained by miRNA mediated regulation of STAT3, and therefore
lend support to our hypothesis that STAT3 is a functional miR-17
family target.
To further test our hypothesis that miR-17 family miRNAs can
target STAT3, we constructed reporter vectors containing a portion
of the STAT3 3′UTR downstream of a CMV promoter-driven
luciferase gene (Fig. 7A). When the miRNAs of interest are present,
they bind to the cloned 3′UTR and silence luciferase expression. Our
positive control vector, pMIR-miR20, contains two synthesized
binding sites that are complementary to the mature miR-20
sequences. The negative control vector, pMIR-Hoxa11, contains the
3′UTR of the Hoxa11 gene, which is not predicted to bind miR-17
family miRNAs and is speciﬁcally silenced by miR-181 during
mammalian myoblast differentiation (Naguibneva et al., 2006). The
experimental vectors used in our studies contain either wild type
(pMIR-S3) or mutant versions of one (pMIR-S3st1mt and pMIR-
S3st2mt) or both (pMIR-S32xmt) of the two putative miRNA binding
sites within the STAT3 3′UTR.
We assayed the luciferase activity of our reporter constructs in
response to endogenous miRNAs over the course of ES cell
differentiation. As hypothesized, the pMIR-S3 construct was silenced
between days 1 and 3 at the onset of ES cell differentiation (Fig. 7B).
The pattern of luciferase activity corresponds to the period of
differentiation during which STAT3 activity is normally downregu-
lated and miR-93 is upregulated (Fig. 5C). Moreover, in Fig. 7B, pMIR-
S3 is highest at d4, suggesting that once ES cells have initiated
differentiation,miRNAs are no longer regulating the STAT3 UTR. This is
supported by Fig. 5 which shows miRNA levels peaking between days
2 and 3 and beginning to show a decrease by d4. To ensure that this
pattern of luciferase activity was actually due to endogenous miRNAs
binding the STAT3 3′UTR and not just an artifact of our system, we
performed the same timecourse experiment using STAT3 3′UTR
mutant constructs (Figs. 7B and S2). The construct containing
mutations in the second miRNA binding site (pMIR-S3st2mt)
displayed some responsiveness to miRNAs at the onset of differentia-
tion but not later in the process (Fig. S2A). In contrast, the site one
mutant (pMIR-S3st1mt) and double mutant (pMIR-S32xmt) con-
structs had an entirely different pattern of luciferase activity when
compared to the wild type STAT3 construct over the course of
differentiation (Figs. 7B and S2A). These two mutant constructsn differentiating ES cells. Cells were transfected in the undifferentiated state and put into
R on days 1, 3, and 7. Transfection of either inhibitor caused a delay in ectodermal
ibitor also blocked endodermal differentiation, resulting in decreased Hnf4a expression
er inhibitor seemed to affect mesodermal differentiation. However, transfection of the
Using the same transfection procedure as above, EBs were cultured for 10 days and then
G, I) a clear outer layer of visceral endoderm, as distinguished by the large vacuoles, is
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Fig. 7. (A) A schematic representation of the pMIR-luciferase reporter constructs used in this study. (B) Transfection of pMIR-S3 (vector containing the STAT3 3′UTR) into ES cells
results in a rapid decrease in luciferase activity once differentiation begins. The decrease in luciferase lasts approximately 2 days and correlates to a period in which STAT3 activity is
known to be reduced (Foshay and Gallicano, 2008; Foshay et al., 2005). Mutation of the miR-17 family binding sites on the STAT3 3′UTR completely changes the pattern of luciferase
expression, suggesting that these are functional miRNA binding sites. All luciferase values are normalized to Renilla luciferase. (C) Dose response curve of STAT3 expression 48 h after
transfectionwith miR-93 mimic. Inset Western blot shows representative results. Values for STAT3 expressionwere generated by calculation of the pixel intensity of each band using
Adobe Photoshop CS, and were normalized to tubulin expression. Data are represented the mean±the SEM (n=3). A reduction in STAT3 expression is seen when concentrations of
greater than 80 nM are used. (D) Luciferase activity of the pMIR-S3 construct alone or co-transfected with inhibitors to miR-20 or miR-93 was analyzed during ES cell differentiation.
Only inhibitors tomiR-93 could prevent the decrease in pMIR-S3 luciferase activity at the onset of differentiation. Neg. Inhib. is a non-speciﬁc inhibitor used as a control. All values are
normalized to Renilla luciferase and presented as the mean±the SEM.
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tion. Together these data suggest that while both miRNA binding sites
on the STAT3 3′UTR are functional, the ﬁrst site is more important for
miRNA binding at the onset of differentiation. Moreover, another
important aspect of these data that must be stressed is that there is
very little change in luc expression in the mutant construct while the
wild-type construct shows dramatic changes in luc expression that
virtually mirror when STAT3 protein is reduced during the initial
stages of ES cell differentiation.
We also tested the effectiveness of these constructs by co-
transfecting them along with mimics or inhibitors to miR-20 or
miR-93. As expected, miR-20 mimics could successfully decrease the
luciferase activity of our positive control vector (pb .02) but not our
negative control vector (Fig. S2B). The miR-20 mimic also induced a
modest but statistically signiﬁcant 25% decrease in luciferase activity
of the pMIR-S3 construct. These data suggest that miR-20 can both
bind to and silence the STAT3 3′UTR. More surprising results were
seen when co-transfecting these same constructs with miR-93
mimics. Speciﬁcally, the miR-93 mimics could not silence the pMIR-
miR20 positive control vector. However, as expected, miR-93 mimics
induced a drastic 50% reduction in luciferase activity from the pMIR-
S3 construct (Fig. S2C). This interesting result suggests, as previously
hypothesized, that miR-93 can more efﬁciently bind to and silenceSTAT3 expression. Additionally, these novel data suggest that factors
other than the seed sequence, which is identical in miR-20 and miR-
93, may regulate binding of miRNAs to target UTRs.
Of note is the increase in pMIR-miR20 luciferase activity in
response to the miR-93 inhibitor (Fig. S2C). While the miRNA mimics
work in a physiological manner (being loaded into the miRNA RISC
silencing complex) the inhibitors simply bind complimentarymiRNAs.
We suggest that the miR-93 inhibitor is capable of binding to and
blocking endogenous miR-20 or other miR-17 family members,
resulting in increased luciferase expression of pMIR-miR20. We see
this effect only when using the positive control vector (which was
designed to bind multiple endogenous miR-17 miRNAs) but not when
we transfect the pMIR-S3 construct. This suggests that binding of
endogenous miR-17 miRNAs to the STAT3 3′UTR is more restricted
than binding to the control sequence.
To test that the decreases in luciferase expression correlated to a
decrease in STAT3 protein, mimics and inhibitors of miR-20 and miR-
93 were transfected into undifferentiated ES cells. After 48 h, lysates
were made and analyzed by Western blot for STAT3 expression. We
constructed a dose response graph and demonstrated a signiﬁcant
decrease in STAT3 when ES cells were transfected with 80–160 nM of
miR-93 mimic (Fig. 7C). Based on these results we chose to use 20 nM
and 100 nM concentrations of miRNAmimics and inhibitors in a larger
Table 2
ES cell associated targets of miR-17 family microRNAs
ES cell associated predicted targets of the miR-17 family
mRNAs Role in ES cells/development
LIF Pluripotency and self-renewal in mouse ES (Cartwright et al., 2005)
STAT3 Pluripotency and self-renewal in mouse ES (Niwa et al., 1998;
Raz et al., 1999); differentiation (Foshay and Gallicano, 2008;
Foshay et al., 2005)
Myc Pluripotency and self-renewal (Cartwright et al., 2005)
Frizzled-1, -4, -7 Pluripotency and self-renewal (Walsh and Andrews, 2003)
Bmp2 Self-renewal (Peerani et al., 2007) or differentiation (Gossrau et al.,
2007; Pera et al., 2004)
Bmpr2 Self-renewal (Peerani et al., 2007) or differentiation (Gossrau et al.,
2007; Pera et al., 2004)
Smad5, 7 Self-renewal (Suzuki et al., 2006; Ying et al., 2003)
This table lists other stem cell and/or differentiation associated mRNAs that are
predicted targets of at least one miR-17 family miRNA. Like STAT3, several of these
proteins are involved in both self-renewal and differentiation. This suggests that
changes in miRNA expression could mediate a shift between self-renewal and
differentiation by downregulating these target mRNAs.
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mimics, transfected at the 100 nM concentration, could signiﬁcantly
reduce STAT3 expression (Fig. S3A). Additionally, this decrease could
be rescued by co-transfection of inhibitors along with mimics,
suggesting that the effects on STAT3 were speciﬁcally caused by the
activity of the miRNA mimics. The co-transfection of mimics to both
miR-20a and miR-93 (each at 50 M) also resulted in a signiﬁcant
decrease in STAT3 expression. However, in this case the decrease was
less than that seen when the miR-93 mimic was transfected alone.
These data suggest that miR-93 may be more efﬁcient at silencing
STAT3 and that perhaps miR-93 and miR-20 do not bind the STAT3 3′
UTR with the same afﬁnity.
To conﬁrm that the decrease in STAT3 expression was due to
downregulation by miRNAs and not a secondary effect of ES cell
differentiation, we transfected negative control or miR-93 mimics
(100 nM) into MDA-MB-231 breast cancer cells (Fig. S3B). In
accordance with our expectations, the miR-93 mimic led to a decrease
in STAT3 protein when compared to reagent only or negative mimic
controls. As STAT3 has no pluripotency function in these cells, any
decrease in STAT3 protein is likely due to miRNA downregulation and
not indirect effects on cellular differentiation.
Finally, to determine which endogenous miRNAs were binding the
STAT3 3′UTR during ES cell differentiation, we repeated our time-
course experiments, this time co-transfecting the inhibitors to either
miR-20 or miR-93 along with the pMIR-S3 construct (Fig. 7D). While
transfection of the miR-20 inhibitor had a slight effect on the pattern
of pMIR-S3 luciferase expression, a decrease in luciferase activity was
still observed at the onset of differentiation. Only transfection of miR-
93 inhibitors completely prevented the decrease of luciferase activity
at the onset of differentiation, closely resembling the pattern of
luciferase activity seen with the pMIR-S32xmt construct (Fig. 7B).
These data strongly suggest that endogenous miR-93 binds to and
silences the STAT3 during ES cell differentiation.
Discussion
While the current literature has demonstrated that ES cells express
a unique set of miRNAs, few studies clearly deﬁne a functional
consequence of miRNA expression in this model system. In this
manuscript we have not only identiﬁed a family of miRNAs that are
present in ES cells, but we have conﬁrmed their existence in
developing mammalian embryos and linked their expression to a
functional role in the regulation of ES cell differentiation.
Although the knockout mouse has become the gold standard for
identifying the effects of speciﬁc genes on embryonic development
and cellular differentiation, several confounding factors decreased the
usefulness of a knockout mouse model in this study. First, as the miR-
17 family of miRNAs has been duplicated throughout evolution, many
of these miRNAs exhibit high sequence homology and most likely
overlapping functions. Due to this redundancy, the knockout of any
single miR-17 family miRNA most likely would not provide clear
insight into its role in development. A second option would be a
knockout of the entire miR-17 family. Because this family exists as
three clusters on three separate chromosomes, this endeavor would
be technically challenging and may disguise any divergent miRNA
functions. Thus, to elucidate both unique and redundant miRNA
functions, knockouts of each miR-17 family member would have to be
generated and screened for mutants that phenocopy one another.
However, the creation of 14 individual knockouts would be an overly
ambitious project. Taking all of these issues into consideration, we
believe that the ES model system is currently the best system for
examining the functions of individual miRNAs within miRNA families
during embryonic development.
As the miR-17 family of miRNAs is expressed as polycistronic
clusters, we were not surprised to ﬁnd several members of this family
expressed in both ES cells and embryos. However, within this family,individualmiRNAswere clearly expressed at different levels in different
cell types both in vivo and in vitro (Figs. 2–5). In addition, thesemiRNAs
seemed to function differently in different germ layers (Fig. 6). These
data suggest that miRNA expression is tightly regulated and simple
transcription of the miRNA genes does not necessarily correlate to or
predict expression and function of the mature form. This idea is
supported by current investigations on post-transcriptional miRNA
processing by Drosha in cancer cells (Thomson et al., 2006). Thus, we
suggest that investigation into the varyingmechanism thatmay control
splicingof polycistronic transcripts andprocessingof precursor forms is
necessary to completely understand the actions of miRNAs.
In addition to highlighting the tight regulation of miRNA expres-
sion during development, our data also allude to the fact that “seed
sequence” recognition is not sufﬁcient to predict miRNAs binding.
Although several algorithms predicted binding of miR-17 family
members to STAT3, differences in binding afﬁnity were clear.
Speciﬁcally, in light of the identical core and other sequence
similarities between miR-93 and miR-20, it was surprising that miR-
93 could not silence the pMIR-miR20 positive control vector. And yet,
miR-93was able to silence the STAT3 3′UTRmore efﬁciently thanmiR-
20. Based on these interesting data, it is apparent that better
algorithms and amore detailed understanding of bindingmechanisms
are needed to predict functional miRNA:mRNA pairs.
Our data demonstrate the functionality of miR-93 and STAT3
binding as a mechanism for inducing murine ES cell differentiation.
However, as the role of STAT3 in human and mouse ES cells varies, the
question of the importance and conservation of this interaction in
human development begs to be answered. Although the human ES
cell experiments have not and cannot be conducted in our laboratory
due to ethical policies at Georgetown University, we predict that the
role of miRNA regulation of STAT3 in ES cell differentiation is
conserved between species. First, it is important to note that we are
not referring to promotion of self-renewal but to inhibition of
differentiation. Although STAT3 is not necessary for self-renewal in
mouse or human ES cells, it is still expressed at high levels (Darr and
Benvenisty, 2006; Kristensen et al., 2005). Thus, it is completely
probable that downregulation of STAT3 is necessary at the onset of
both mouse and human ES cell differentiation. This idea is supported
by the fact that STAT3 regulates differentiation of several different cell
types, including hematopoietic stem cells and neural stem cells
(Chung et al., 2006; Foshay and Gallicano, 2008; Foshay et al., 2005;
Hevehan et al., 2002; Hirabayashi and Gotoh, 2005; Krichevsky et al.,
2006; Smithgall et al., 2000). In addition, at least one member of the
miR-17 family of miRNAs, miR-17-5p, is expressed in human ES cells
(Suh et al., 2004) and several miR-17 family miRNAs are predicted to
bind the human STAT3 3′UTR. Thus, as all of the players necessary for
the STAT3-miRNA interaction are present, we believe that within
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downregulate STAT3 at the onset of differentiation. Further support of
this hypothesis comes from Ventura et al. (2008) who demonstrated
that mice deﬁcient for miR-17–92 die shortly after birth with heart
and lung defects. More importantly, double and triple knockouts (DKO
or TKO) of paralogs die prior to E15, suggesting that mature miRNAs
from these paralogs can compensate for one another. Since the major
defects in the DKO and TKO embryos as shown by Ventura et al. (2008)
were cardiac defects and our previous papers as well as others within
the literature have established a role for STAT3 in heart development,
we believe the phenotype observed in the Ventura paper supports the
idea that this family of miRNAs maintains appropriate levels of STAT3
during differentiation.
Although our novel data clearly demonstrate that modulation of
miR-93 and miR-20 expression can alter fate commitment during ES
cell differentiation, several questions remain. One such question is
whether STAT3 is the only target mRNA responsible for mediating the
effects of miR-17 family miRNAs. As miRNAs exhibit promiscuous
binding, it is likely that other stem cell or differentiation associated
mRNAs are also functionally downregulated by these same miRNAs.
Using a bioinformatics based approach, we generated a table of miR-
17 family target mRNAs that could also be responsible for regulating
the onset of ES cell differentiation (Table 2). Interestingly, this family
of miRNAs seems to target players in all of the major stem cell self-
renewal pathways, including c-Myc, Wnt, BMP, and STAT3 signaling.
The fact that c-Myc is a predicted target of this family of miRNAs
may be highly important as c-Myc has recently been shown to be a
factor controlling pluripotency and early differentiation. C-Myc was
one of four genes capable of generating induced pluripotent stem cells
(iPS cells) from various somatic cell types (Wernig et al., 2008;
Takahashi and Yamanaka, 2006). We would expect that members of
the miR-17 family upon increase in expression would quickly down
regulate c-Myc andWnt mRNAs resulting in inhibition of self-renewal
(Kristensen et al., 2005). C-myc is also involved in many cancers
(Soucek et al., 2008) suggesting that mis-regulation of miR-17 family
ofmiRNAsmay be involved in the etiology of c-Myc induced cancers. It
is enticing to speculate that these small miRNA molecules could be
used to down-regulate c-Myc in these cancers. In any event, this level
of understanding miRNA function within each pathway will most
likely be necessary for determining the control mechanism(s) that
differentiate ES cells and/or iPS cells into desired cell types (i.e.,
cardiomyocytes, neurons, b-islet cells, etc.).
While studies of miRNA function in ES cell differentiation may
yield interesting new ideas for stem cell therapeutics, the role of
miRNAs in embryonic development is equally as important and
interesting. Our in vivo mouse embryo studies suggest that miR-93
could play a role in STAT3 regulation during gastrulation. Recent
studies in the zebraﬁsh have revealed that STAT3 can regulate cell
migration, polarity, and anterior–posterior axis formation during
gastrulation of the zebraﬁsh embryo (Miyagi et al., 2004; Sepich et al.,
2005; Yamashita et al., 2002). Based on our in situ hybridization
experiments and this current literature, we plan to further assess the
function of miR-93 during formation of the primitive streak,
gastrulation, and axis formation.
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